Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and tolerability of two Humira formulations in adults with rheumatoid arthritis
2011-002275-41Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Dec 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Started Dec 2011; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2011-002275-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002275-41.